CVS Health Corporation CVS NYSE

CVS Health Corporation (CVS) has shown moderate revenue growth over the past 3 years, expanding from $322.5B to $402.1B (average +7.7%/yr). Net income reached $1.8B, reflecting earnings decline at -4.3%/yr on average. The net profit margin is 0.4%, which is thin. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 13.8% (low), with a -3.1pp trend over the period. With a $99B market cap and MOAT composite score of 51/100, the company has a moderate competitive position.

Criteria proven by this page:

• GROWTH (40/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 43-year history, the company was profitable in 41 of 43 years — an excellent long-term track record
• INCOME (30/100, Partial) — the company is profitable but margin is below 15%
• MOAT (51/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 55/100 with 2/7 criteria passed.